Clinical Trial Update: A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B. [Phase 3]

View source ↗

Summary

Phase IIIc clinical trial to evaluate the long-term use of Hydronidone capsules for liver fibrosis in patients with chronic hepatitis B; status is NOT_YET_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis

Drugs mentioned

• Hydronidone (Hydronidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Liver Fibrosis, Liver Fibrosis in Chronic Hepatitis B | Phase 3 | Status: NOT_YET_RECRUITING